K

Kerecis

Biotech & Life Sciences · Ísafjörður, Iceland · Founded 2010

Kerecis is a pioneering startup that operates in the healthcare sector, specifically in wound care. The company has developed an innovative solution for treating complex wounds, burns, and other acute and chronic wounds, including those resulting from diabetes, venous issues, trauma, and surgery. The treatment involves the use of intact fish skin, sourced from wild Atlantic cod caught in the pristine waters of Iceland. This fish skin is processed using renewable energy, underscoring the company's commitment to sustainability. The company's primary clients are patients suffering from stubborn wounds that are not healing properly. Kerecis has successfully treated thousands of patients across different income levels, cultures, and races, demonstrating the broad applicability and effectiveness of its solution. The story of Alana Smith, a real estate agent from Palo Alto, California, who was at risk of losing a limb due to a stubborn wound, is a testament to the company's impact. With Kerecis' treatment, her wound healed, saving her limb. Kerecis operates in the global wound care market, which is a growing sector due to the increasing prevalence of chronic diseases such as diabetes. The company's business model involves the sale of its fish-skin treatment to healthcare providers, who then administer it to patients. This approach allows Kerecis to generate revenue while providing a much-needed solution to a pressing healthcare issue. Keywords: Healthcare, Wound Care, Fish Skin, Sustainable, Renewable Energy, Chronic Wounds, Diabetic Wounds, Trauma Wounds, Surgical Wounds, Global Market.